| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_026c8f18d6b731e74f69f478a4eaafae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f85564418d5538590b43888e73e2dee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6030e596e59c47263cb82066bc6f28b0 |
| publicationDate |
2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019132839-A1 |
| titleOfInvention |
Oral pharmaceutical compositions of dabigatran |
| abstract |
The present invention relates to pharmaceutical compositions for an oral administration comprising a first component comprising dabigatran etexilate free base or pharmaceutically acceptable salts of dabigatran etexilate and a second component comprising an organic acid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112266475-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112266475-B |
| priorityDate |
2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |